|
ONCOLYTICS BIOTECH INC.
|
|
RSS 
Printer friendly
Subscribe to Portfolio e-mail
 |
| September 9, 2010 |
|
Media Advisory - Oncolytics Biotech(R) Inc. to Present at Rodman & Renshaw Annual Global Investment Conference
|
|
7:30 ET
|
| September 2, 2010 |
|
Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute
|
|
7:30 ET
|
| August 5, 2010 |
|
Media Advisory - Oncolytics Biotech(R) Inc. to Present at 30th Annual Canaccord Genuity Growth Conference
|
|
7:30 ET
|
| July 29, 2010 |
|
Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results
|
|
7:30 ET
|
| July 19, 2010 |
|
Oncolytics Biotech(R) Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN(R) in Head and Neck Cancers
|
|
7:30 ET
|
| June 17, 2010 |
|
Oncolytics Biotech(R) Inc. Announces Issuance of 35th U.S. Patent
|
|
7:30 ET
|
| June 7, 2010 |
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Updated U.K. Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the ASCO Annual Meeting
|
|
7:30 ET
|
| June 4, 2010 |
|
Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting
|
|
7:30 ET
|
| June 3, 2010 |
|
Media Advisory - Oncolytics Biotech(R) Inc. to Present at the 9th Annual Needham Healthcare Conference
|
|
7:30 ET
|
| June 1, 2010 |
|
Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
|
|
7:30 ET
|
|
RSS Printer friendly
Subscribe to Portfolio e-mail
